Nabriva Therapeutics Plc (NBRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBRV | AMGN | GILD | VRTX | BIIB |
| Company | Nabriva Therapeutics Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.4500 | 265.72 | 65.50 | 393.52 | 201.22 |
| High | 1.9000 | 271.68 | 66.35 | 399.68 | 209.64 |
| Low | 1.3500 | 265.72 | 64.63 | 393.49 | 199.10 |
| Last | 1.4200 | 271.12 | 65.76 | 398.23 | 209.57 |
| Change | unch | +1.74 | +0.49 | +0.53 | +7.11 |
| % Change | unch | +0.65% | +0.75% | +0.13% | +3.51% |
| Volume | 717,200 | 894,460 | 7,835,217 | 309,924 | 1,106,608 |
| 20-Day Average Volume | 46,640 | 2,076,950 | 6,823,600 | 923,753 | 1,237,449 |
| Previous Close | 1.4200 | 269.38 | 65.27 | 397.70 | 202.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5446 | 270.04 | 68.30 | 401.36 | 201.15 |
| 20-Day Raw Stochastic | 12.73% | 44.86% | 11.93% | 26.69% | 75.73% |
| 20-Day Relative Strength | 42.54% | 46.67% | 30.57% | 44.00% | 50.14% |
| Weighted Alpha | -50.30 | +10.08 | -23.10 | +15.44 | -31.45 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 8% Buy | 80% Sell |
| Previous Opinion | 100% Sell | 72% Sell | 100% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 88% Sell | 40% Buy | 88% Sell | 56% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.35% since 07/24/23 | +0.81% since 04/19/24 | -1.66% since 04/19/24 | +1.23% since 04/19/24 | +7.69% since 04/19/24 |
| Low | 1.3500 on 07/31/23 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 393.00 on 04/25/24 | 192.75 on 04/23/24 |
| High | 1.9000 on 07/31/23 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 | 209.64 on 04/26/24 |
| 1-Month | |||||
| %Chg | -5.96% since 06/30/23 | -3.79% since 03/26/24 | -9.33% since 03/26/24 | -4.62% since 03/26/24 | -1.27% since 03/26/24 |
| Low | 1.3500 on 07/31/23 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 1.9000 on 07/31/23 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 217.57 on 03/28/24 |
| 3-Month | |||||
| %Chg | -11.26% since 04/28/23 | -13.04% since 01/26/24 | -17.44% since 01/26/24 | -7.21% since 01/26/24 | -14.50% since 01/26/24 |
| Low | 1.3500 on 07/31/23 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 2.2400 on 05/19/23 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | -8.39% since 01/30/23 | +0.52% since 10/26/23 | -16.36% since 10/26/23 | +10.48% since 10/26/23 | -13.17% since 10/26/23 |
| Low | 1.2600 on 03/27/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 2.2400 on 05/19/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 45,461 | 144,488,960 | 81,266,176 | 102,789,152 | 29,429,788 |
| Shares Outstanding, K | 32,015 | 536,376 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 36,940,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -57,190,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 7,590,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -8,700,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 1.53 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.72 on 05/22/23 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 08/02/23 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 29.82 | 13.47 |